[Comment on S. Gabius, H.-J. Gabius: Immune modulating mistletoe therapy by lectin standardization: a double-edged sword?].
Wetzel
D
D
Mengs
U
U
Schwarz
T
T
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D028321:Plant Preparations; D010940:Plant Proteins; D051381:Rats; D054790:Ribosome Inactivating Proteins, Type 2; D014118:Toxins, Biological / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014410:Tumor Stem Cell Assay
D000276:Adjuvants, Immunologic; D028321:Plant Preparations; D010940:Plant Proteins; D054790:Ribosome Inactivating Proteins, Type 2; D014118:Toxins, Biological; C009674:ribosome inactivating protein, Viscum